Companies covered: Amazon.com, Inc. (NASDAQ:AMZN), Eldorado Resorts, Inc. (NASDAQ:ERI), MGM Resorts International (NYSE:MGM), Scientific Games Corp (NASDAQ:SGMS), Golden Entertainment Inc (NASDAQ:GDEN), Hilton Hotels Corporation (NYSE:HLT), Marriott International (NASDAQ:MAR), Caesars Entertainment Corporation (NASDAQ:CZR), Hyatt Hotels Corporation (NYSE:H), Las Vegas Sands Corp. (NYSE:LVS), Wynn Resorts, Limited (NASDAQ:WYNN), Salesforce.com Inc (NYSE:CRM), Monarch Casino & Resort, Inc. (NASDAQ:MCRI), McDonald's Corporation (NYSE:MCD), Chipotle Mexican Grill, Inc. (NYSE:CMG), Darden Restaurants, Inc. (NYSE:DRI), Brinker International, Inc. (NYSE:EAT), Starbucks Corporation (NASDAQ:SBUX), Restaurant Brands International Inc. (NYSE:QSR), Potbelly Corporation (NASDAQ:PBPB), Dunkin' Brands Group, Inc. (NASDAQ:DNKN), Yatra Online, Inc. (NASDAQ:YTRA), Belmond Ltd. (NYSE:BEL)
Companies covered: General Mills, Inc. (NYSE:GIS), Unilever NV (NYSE:UL), Amazon.com, Inc. (NASDAQ:AMZN), Polaris Industries Inc. (NYSE:PII), WPT Industrial Real Estate Investment (TSE:WIR.U), Twilio Inc (NYSE:TWLO), Vonage Holdings Corp. (NYSE:VG), Mimecast Ltd. (NASDAQ:MIME), Microsoft Corporation (NASDAQ:MSFT), Proofpoint, Inc. (NASDAQ:PFPT), Cisco Systems, Inc. (NASDAQ:CSCO), Corecivic Inc (NYSE:CXW), MasTec, Inc. (NYSE:MTZ), United Parcel Service, Inc. (NYSE:UPS), FedEx Corporation (NYSE:FDX), Franklin Resources, Inc. (NYSE:BEN), Medtronic, Inc. (NYSE:MDT), Bank Of New York Mellon Corporation (The) (NYSE:BK), Visa Inc. (NYSE:V), International Business Machines Corporation (NYSE:IBM), General Electric Company (NYSE:GE), Walmart Inc. (NYSE:WMT), Best Buy Co., Inc. (NYSE:BBY), Macy's Inc (NYSE:M), Coca-Cola Company (The) (NYSE:KO), Costco Wholesale Corporation (NASDAQ:COST), Chipotle Mexican Grill, Inc. (NYSE:CMG), McDonald's Corporation (NYSE:MCD), Facebook, Inc. (NASDAQ:FB)
Companies covered: Sangamo Therapeutics, Inc. (NASDAQ:SGMO), Novartis AG (NYSE:NVS), Gilead Sciences, Inc. (NASDAQ:GILD), bluebird bio, Inc. (NASDAQ:BLUE), Cellectis S.A. (NASDAQ:CLLS), Monsanto Company (NYSE:MON), Illumina, Inc. (NASDAQ:ILMN), Foundation Medicine, Inc. (NASDAQ:FMI), CRISPR Therapeutics AG (NASDAQ:CRSP), uniQure N.V. (NASDAQ:QURE), Spark Therapeutics, Inc. (NASDAQ:ONCE), AveXis Inc (NASDAQ:AVXS), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Regenxbio Inc (NASDAQ:RGNX), Oxford BioMedica plc (LON:OXB), Editas Medicine (NASDAQ:EDIT), Intellia Therapeutics (NASDAQ:NTLA), GenSight Biologics SA (OTCMKTS:GSGTF), ToolGen (KONEX:199800), Lysogene SA (EPA:LYS), Applied Genetic Technologies Corporation (NASDAQ:AGTC), Adaptimmune Therapeutics plc (NASDAQ:ADAP), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Intrexon Corporation (NYSE:XON), Pfizer, Inc. (NYSE:PFE), Celgene Corporation (NASDAQ:CELG), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Solid Biosciences (NASDAQ:SLDB), Rocket Pharmaceuticals (NASDAQ:RCKT), Audentes Therapeutics (NASDAQ:BOLD), Fibrocell Science Inc (NASDAQ:FCSC)
Companies covered: AbbVie Inc. (NYSE:ABBV), Walmart Inc. (NYSE:WMT), Amazon.com, Inc. (NASDAQ:AMZN), United States Steel Corporation (NYSE:X), Xerox Corporation (NYSE:XRX), General Motors Company (NYSE:GM), Square Inc (NYSE:SQ), Apple Inc. (NASDAQ:AAPL), Paypal Holdings Inc (NASDAQ:PYPL), Visa Inc. (NYSE:V), Mastercard Incorporated (NYSE:MA), eBay Inc. (NASDAQ:EBAY), Facebook, Inc. (NASDAQ:FB), Electronic Arts Inc. (NASDAQ:EA), Alphabet Inc (NASDAQ:GOOG), Tencent Holdings Ltd. (OTCMKTS:TCEHY), Alibaba Group Holding Limited (NYSE:BABA)
Companies covered: Spero Therapeutics, Inc. (NASDAQ:SPRO), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Biogen Inc. (NASDAQ:BIIB), Celgene Corporation (NASDAQ:CELG), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Pfizer, Inc. (NYSE:PFE), AbbVie Inc. (NYSE:ABBV), Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM), Cellectis S.A. (NASDAQ:CLLS), Celsion Corporation (NASDAQ:CLSN), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Catabasis Pharmaceuticals Inc (NASDAQ:CATB), Roche Holdings Ltd. (ADR) (OTCMKTS:RHHBY), Amgen Inc. (NASDAQ:AMGN), Gilead Sciences, Inc. (NASDAQ:GILD), Summit Therapeutics PLC (NASDAQ:SMMT), Spark Therapeutics, Inc. (NASDAQ:ONCE), Sage Therapeutics, Inc. (NASDAQ:SAGE), Achaogen Inc (NASDAQ:AKAO), Nabriva Therapeutics plc (NASDAQ:NBRV), Race Oncology Ltd. (ASX:RAC), Soligenix, Inc. (NASDAQ:SNGX), TiGenix (NASDAQ:TIG), Merck & Company, Inc. (NYSE:MRK), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), CRISPR Therapeutics AG (NASDAQ:CRSP), RXI Pharmaceuticals Corporation (NASDAQ:RXII), Oncolytics Biotech, Inc. (USA) (OTCMKTS:ONCYF), Cardiome Pharma Corporation (NASDAQ:CRME), Checkpoint Therapeutics Inc (NASDAQ:CKPT), Resverlogix Corp. (OTCMKTS:RVXCF), Illumina, Inc. (NASDAQ:ILMN), Pacific Biosciences of California, Inc. (NASDAQ:PACB)
